- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0084749

Fertolife Sciences Private Limited
About Fertolife Sciences Private Limited
Data last updated:
Fertolife Sciences Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 22 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PTC305417. Its GSTIN is 27AADCF3146J1ZM (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Vaishali Nitin Wasule and Nitin Lalji Wasule.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.A/13 Abhinav Colony Sita Nagar Somalwada Wardha Road, Nagpur, Maharashtra, India – 440025.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.74 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.81 Lakh (net margin 0.4%) and EBITDA of ₹7.75 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 33% over five years.
Fertolife Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0084749).
Company details
Recognitions & Rankings of Fertolife Sciences
Contact details
Fertolife Sciences Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.A/13 Abhinav Colony Sita Nagar Somalwada Wardha Road, Nagpur, Maharashtra, India – 440025
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Fertolife Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fertolife Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fertolife Sciences Private Limited, buy the company report.
Financials of Fertolife Sciences Private Limited
FY 2025 filings availableFertolife Sciences Private Limited reported revenue of ₹4.74 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 4% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fertolife Sciences Private Limited, buy the company report.
Board of directors of Fertolife Sciences Private Limited
Fertolife Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaishali Nitin Wasule | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Nitin Lalji Wasule | Director | 22 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Fertolife Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Radical Meditech Private Limited | ₹4.76 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Orlem Pharma Private Limited | ₹4.76 Cr (FY 2025) | -1.0% | Ernakulam, Kerala, India | |||
| SSR Medicare Private Limited | ₹4.76 Cr (FY 2025) | 100.0% | Delhi, India | |||
| Fertolife Sciences Private Limitedthis company | ₹4.74 Cr (FY 2025) | ₹1.81 Lakh | 0.4% | 4.0% | Nagpur, Maharashtra, India | |
| Reticine Pharmaids Limited | ₹4.74 Cr (FY 2025) | 64.0% | Chandigarh, India | |||
| Inhalation Health Private Limited | ₹4.72 Cr (FY 2025) | 109.0% | Mumbai, Maharashtra, India | |||
| Axodin Pharmaceuticals Private Limited | ₹4.72 Cr (FY 2025) | 7.0% | Ambala, Haryana, India | |||
| Glivita Pharma Private Limited | ₹4.7 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Fertolife Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fertolife Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fertolife Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fertolife Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCF3146J1ZM | Maharashtra | Active | 12 Mar 2018 |
To see the full GST registrations and return filing status of Fertolife Sciences Private Limited, buy the company report.
Recent activity
Fertolife Sciences Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Prashant Vasant Laxane ceased to be Director on 22 Sep 2018.
Frequently asked questions
Fertolife Sciences is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 22 February 2018 (8+ years old) and is registered under CIN U24304MH2018PTC305417.
Fertolife Sciences has 2 current directors:
- Vaishali Nitin Wasule - Director
- Nitin Lalji Wasule - Director
The latest financial statements of Fertolife Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Fertolife Sciences is 27AADCF3146J1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Fertolife Sciences is U24304MH2018PTC305417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fertolife Sciences was incorporated on 22 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Fertolife Sciences by revenue are Radical Meditech Private Limited, Orlem Pharma Private Limited, SSR Medicare Private Limited, Reticine Pharmaids Limited, Inhalation Health Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prashant Vasant Laxane ceased to be Director on 22 Sep 2018. Vaishali Nitin Wasule was appointed as Director on 20 Sep 2018. Nitin Lalji Wasule was appointed as Director on 22 Feb 2018.
Yes, Fertolife Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0084749).
The registered office of Fertolife Sciences is at Plot No.A13 Abhinav Colony Sita Nagar Somalwada Wardha Road, Nagpur, Maharashtra, India – 440025.
Fertolife Sciences operates in the food and beverages industry, in the manufacturing segment.